Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report)’s stock price gapped up prior to trading on Wednesday . The stock had previously closed at $9.50, but opened at $10.60. Oxford BioMedica shares last traded at $10.60, with a volume of 100 shares trading hands.
Oxford BioMedica Stock Performance
The company has a debt-to-equity ratio of 3.08, a quick ratio of 1.67 and a current ratio of 1.89. The company’s 50 day moving average is $8.54 and its 200-day moving average is $7.44.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
Featured Stories
- Five stocks we like better than Oxford BioMedica
- Buy This Stock at 9:30 AM on MONDAY!
- Punch these codes into your ordinary brokerage account
- This AI Opportunity Was Built to Evolve With Demand
- Trump Planning to Use Public Law 63-43: Prepare Now
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20240604134456&h=45&w=95&zc=2){kind=logo}